Edgen Stock·Nov 26 2025, 04:03返回
返回
Innate Pharma獲FDA批准Lacutamab三期試驗，公布財務可支撐至2026年第三季度
Edgen Stock·Nov 26 2025, 04:03
[1] Innate Pharma宣布FDA批准其繼續進行... (https://www.innate-pharma.com/media/all-press ...)[2] Innate Pharma獲得FDA批准進行三期試驗... (https://trial.medpath.com/news/a85c8cb4270b5d ...)[3] Innate Pharma獲得FDA批准進行Lacutamab三期試驗 (https://www.tipranks.com/news/company-announc ...)